Zolmitriptane as Prophylaxis for Chilhood Migraine

Phase 4

Recruiting

• Conditions: Migraine
• Interventions: Drug: zolmitriptanee; Drug: topiramate; Drug: Valproate

• Registration Number: NCT06089356
• Lead Sponsor: Tanta University

Brief Summary

zolmitriptane can be tried as prophylactic therapy of childhood migraine

Detailed Description

90 children with migraine included in the study first group 30 received zolmitriptane second group 30 received topiramate third group 30 received valproate

Study Timeline

• Study Start: 2023-01-01
• Status Verified: 2023-10
• Study First Submitted: 2023-10-13
• Study First Submitted QC: 2023-10-13
• Last Update Submitted: 2023-10-13
• Study First Posted: 2023-10-18
• Last Update Posted: 2023-10-18
• Primary Completion: 2024-01-01
• Study Completion: 2024-01-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

children with migraine -

Exclusion Criteria

those who suffer from ischemic heart disease , or who have allergy to any of drugs used

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
zolmitriptane	zolmitriptanee	zolmitriptane tablet daily
topiramate	topiramate	topiramate tablet daily
valproate	Valproate	valproate once daily

Primary Outcome Measures

Name	Time	Method
number and severity of migraine attacks	6 months

Trial Locations

Locations (1)

Kafrelsheikh University; 🇪🇬 Tanta, Kafrelsheikh, Egypt